Skip to main content
. Author manuscript; available in PMC: 2017 Aug 28.
Published in final edited form as: Nanoscale. 2015 Mar 14;7(10):4432–4442. doi: 10.1039/c4nr06069e

Fig. 4.

Fig. 4

MTS (a) and clonogenic (b) assays in the PSMA+ PC3 PIP prostate cancer cell line, indicating lack of significant nanoparticle toxicity in the studied BNF concentration range as depicted by cell viability and colony formation assays.